|
1
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeichner SB, Terawaki H and Gogineni K: A
review of systemic treatment in metastatic triple-negative breast
cancer. Breast Cancer (Auckl). 10:25–36. 2016.PubMed/NCBI
|
|
3
|
Abdel-Fatah TMA, Agarwal D, Liu DX,
Russell R, Rueda OM, Liu K, Xu B, Moseley PM, Green AR, Pockley AG,
et al: SPAG5 as a prognostic biomarker and chemotherapy
sensitivity predictor in breast cancer: A retrospective, integrated
genomic, transcriptomic, and protein analysis. Lancet Oncol.
17:1004–1018. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cetin I and Topcul M: Triple negative
breast cancer. Asian Pac J Cancer Prev. 15:2427–2431. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Park YH, Jung HH, Ahn JS and Im YH: Statin
induces inhibition of triple negative breast cancer (TNBC) cells
via PI3K pathway. Biochem Biophys Res Commun. 439:275–279. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ma CX, Cai S, Li S, Ryan CE, Guo ZF,
Schaiff WT, Lin L, Hoog J, Goiffon RJ, Prat A, et al: Targeting
Chk1 in p53-deficient triple-negative breast cancer is
therapeutically beneficial in human-in-mouse tumor models. J Clin
Invest. 122:1541–1552. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jitariu AA, Cimpean AM, Ribatti D and
Raica M: Triple negative breast cancer: The kiss of death.
Oncotarget. 8:46652–46662. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhao W, Zhu H, Zhang S, Yong H, Wang W,
Zhou Y, Wang B, Wen J, Qiu Z, Ding G, et al: Trop2 is overexpressed
in gastric cancer and predicts poor prognosis. Oncotarget.
7:6136–6145. 2016.PubMed/NCBI
|
|
9
|
McDougall AR, Tolcos M, Hooper SB, Cole TJ
and Wallace MJ: Trop2: From development to disease. Dev Dyn.
244:99–109. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Jiang X and Zhang W: TROP2
overexpression promotes proliferation and invasion of lung
adenocarcinoma cells. Biochem Biophys Res Commun. 470:197–204.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cubas R, Zhang S, Li M, Chen C and Yao Q:
Trop2 expression contributes to tumor pathogenesis by activating
the ERK MAPK pathway. Mol Cancer. 9:2532010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Guerra E, Trerotola M, Dell' Arciprete R,
Bonasera V, Palombo B, El-Sewedy T, Ciccimarra T, Crescenzi C,
Lorenzini F, Lorenzini F, et al: A bicistronic CYCLIN
D1-TROP2 mRNA chimera demonstrates a novel oncogenic mechanism
in human cancer. Cancer Res. 68:8113–8121. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wu Y, Zhang L, Zhang L, Wang Y, Li H, Ren
XB, Wei F, Yu WW, Liu T, Wang X, et al: Long non-coding RNA HOTAIR
promotes tumor cell invasion and metastasis by recruiting EZH2 and
repressing E-cadherin in oral squamous cell carcinoma. Int J Oncol.
46:2586–2594. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bai ZT, Wu ZR, Xi LL, Li X, Chen P, Wang
FQ, Meng WB, Zhou WC, Wu XA, Yao XJ, et al: Inhibition of invasion
by N-trans-feruloyloctopamine via AKT, p38MAPK and EMT related
signals in hepatocellular carcinoma cells. Bioorg Med Chem Lett.
27:989–993. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang Y, Zhang J, Yan Y, Cai H, Li M, Sun
K, Wang J, Liu X, Wang J and Duan X: Low expression of Rap1GAP is
associated with epithelial-mesenchymal transition (EMT) and poor
prognosis in gastric cancer. Oncotarget. 8:8057–8068.
2017.PubMed/NCBI
|
|
16
|
Cong N, Du P, Zhang A, Shen F, Su J, Pu P,
Wang T, Zjang J, Kang C and Zhang Q: Downregulated microRNA-200a
promotes EMT and tumor growth through the wnt/β-catenin pathway by
targeting the E-cadherin repressors ZEB1/ZEB2 in gastric
adenocarcinoma. Oncol Rep. 29:1579–1587. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
He R, Zhang FH and Shen N: LncRNA
FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through
suppressing E-cadherin and regulating WNT pathway in non-small cell
lung cancer (NSCLC). Biomed Pharmacother. 95:331–338. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang J, Chen XY, Huang KJ, Wu WD, Jiang
T, Cao J, Zhou LS, Qiu ZJ and Huang C: Expression of FoxM1 and the
EMT-associated protein E-cadherin in gastric cancer and its
clinical significance. Oncol Lett. 12:2445–2450. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang ZS, Shen Y, Li X, Zhou CZ, Wen YG,
Jin YB and Li JK: Significance and prognostic value of Gli-1 and
Snail/E-cadherin expression in progressive gastric cancer. Tumour
Biol. 35:1357–1363. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chandra Mangalhara K, Manvati S, Saini SK,
Ponnusamy K, Agarwal G, Abraham SK and Bamezai RNK:
ERK2-ZEB1-miR-101-1 axis contributes to
epithelial-mesenchymal transition and cell migration in cancer.
Cancer Lett. 391:59–73. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ahmed NS, Ghatak S, El Masry MS, Gnyawali
SC, Roy S, Amer M, Everts H, Sen CK and Khanna S: Epidermal
E-Cadherin dependent β-catenin pathway is phytochemical inducible
and accelerates anagen hair cycling. Mol Ther. 25:2502–2512. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Garcia-Pedrero JM, Garcia-Cabo P, Ángeles
Villaronga M, Hermida-Prado F, Granda-Diaz R, Allonca E and Rodrigo
JP: Prognostic significance of E-cadherin and β-catenin expression
in HPV-negative oropharyngeal squamous cell carcinomas. Head Neck.
39:2293–2300. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su SC, Hsieh MJ, Yang WE, Chung WH, Reiter
RJ and Yang SF: Cancer metastasis: Mechanisms of inhibition by
melatonin. J Pineal Res. 62:2017. View Article : Google Scholar
|
|
25
|
Pearlman RL, Montes de Oca MK, Pal HC and
Afaq F: Potential therapeutic targets of epithelial-mesenchymal
transition in melanoma. Cancer Lett. 391:125–140. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hao Y, Yang X, Zhang D, Luo J and Chen R:
Long noncoding RNA LINC01186, regulated by TGF-β/SMAD3, inhibits
migration and invasion through Epithelial-Mesenchymal-Transition in
lung cancer. Gene. 608:1–12. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin H, Zhang H, Wang J, Lu M, Zheng F,
Wang C, Tang X, Xu N, Chen R, Zhang D, et al: A novel human Fab
antibody for Trop2 inhibits breast cancer growth in vitro and in
vivo. Int J Cancer. 134:1239–1249. 2014. View Article : Google Scholar : PubMed/NCBI
|
